Wells Fargo & Company Citius Pharmaceuticals, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 4,000 shares of CTXR stock, worth $1,400. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,000

Previous 50,842 92.13%

Holding current value

$1,400

Previous $45,000 95.56%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.58 - $1.03 $27,168 - $48,247	-46,842 Reduced 92.13%	4,000 $2,000
Q1 2024 May 10, 2024	BUY	$0.6 - $0.9 $5,673 - $8,510	9,456 Added 22.85%	50,842 $45,000
Q4 2023 Feb 09, 2024	BUY	$0.65 - $0.86 $4,847 - $6,413	7,458 Added 21.98%	41,386 $31,000
Q3 2023 Nov 13, 2023	SELL	$0.65 - $1.25 $11,406 - $21,935	-17,548 Reduced 34.09%	33,928 $23,000
Q2 2023 Aug 15, 2023	BUY	$1.08 - $1.65 $50,269 - $76,800	46,546 Added 944.14%	51,476 $61,000
Q1 2023 May 12, 2023	BUY	$0.78 - $1.42 $10 - $19	14 Added 0.28%	4,930 $5,000
Q4 2022 Feb 13, 2023	BUY	$0.79 - $1.28 $18 - $29	23 Added 0.47%	4,916 $3,000
Q3 2022 Nov 14, 2022	SELL	$0.14 - $1.33 $0 - $9	-7 Reduced 0.14%	4,893 $6,000
Q2 2022 Aug 12, 2022	SELL	$0.88 - $1.87 $21,843 - $46,417	-24,822 Reduced 83.51%	4,900 $5,000
Q1 2022 May 16, 2022	SELL	$1.38 - $1.89 $51,661 - $70,754	-37,436 Reduced 55.74%	29,722 $53,000
Q4 2021 Feb 14, 2022	SELL	$1.51 - $2.2 $877,977 - $1.28 Million	-581,442 Reduced 89.65%	67,158 $103,000
Q3 2021 Nov 15, 2021	BUY	$1.74 - $2.6 $1.12 Million - $1.67 Million	644,062 Added 14192.64%	648,600 $1.32 Million
Q2 2021 Aug 16, 2021	BUY	$1.51 - $4.23 $2,746 - $7,694	1,819 Added 66.9%	4,538 $15,000
Q1 2021 May 13, 2021	BUY	$1.04 - $2.34 $473 - $1,064	455 Added 20.1%	2,719 $5,000
Q4 2020 Feb 09, 2021	BUY	$0.9 - $1.2 $14 - $19	16 Added 0.71%	2,264 $2,000
Q3 2020 Nov 05, 2020	BUY	$0.83 - $1.51 $109 - $199	132 Added 6.24%	2,248 $2,000
Q2 2020 Aug 13, 2020	SELL	$0.65 - $1.45 $10,705 - $23,881	-16,470 Reduced 88.62%	2,116 $2,000
Q1 2020 May 14, 2020	BUY	$0.46 - $1.3 $8,549 - $24,161	18,586 New	18,586 $11,000

Others Institutions Holding CTXR

# of Institutions

Shares Held

30.6M

Call Options Held

24.7K

Put Options Held

View Full List

About Citius Pharmaceuticals, Inc.

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $51.1M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

More about CTXR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Citius Pharmaceuticals, Inc. Transaction History